Title : A chitosan-mediated inhalable nanovaccine against SARS-CoV-2.

Pub. Date : 2022

PMID : 35126879

1 Functional Relationships(s)
Compound Name
Protein Name
1 The chitosan-mediated nanovaccine enabled a strong spike-specific antibody immune response and augmented local mucosal immunity in bronchoalveolar lavage and lungs, which might be capable of protecting the host from infection without systemic toxicity. nanovaccine surface glycoprotein Severe acute respiratory syndrome coronavirus 2